Clinical Trials

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Meningioma, Oligodendroglioma, Central Nervous System Neoplasms, Glioma, Subependymal, Gliosarcoma

NCT00867113 2018-03-14

Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST)

91 enrolled 11 charts

Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors

NCT00455559 2018-02-22

Ph II Study of Perifosine Plus Gleevec for Patients With GIST

40 enrolled

Gastrointestinal Stromal Tumors

NCT01172548 2017-05-31

INV555

132 enrolled

Recurrence, Gastrointestinal Stromal Tumors

NCT01137916 2017-05-03

Study to Evaluate Imatinib in Desmoid Tumors

39 enrolled

Desmoid Tumors

NCT00150072 2017-02-23

Efficacy and Safety of Imatinib in Chordoma

55 enrolled

Chordoma

NCT00171912 2017-02-23

Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes

MyeloidOther hematologic neoplasmSarcomaThoracic

38 enrolled

Lung Neoplasms, Leukemia, Myelomonocytic, Chronic, Hypereosinophilic Syndrome, Dermatofibrosarcoma, Mastocytosis, Systemic, Leukemia, Myelomonocytic, Juvenile

NCT00154388 2016-11-18

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

BreastDermatologicGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmOther solid neoplasmPlasma cellSarcomaThoracic

185 enrolled

Malignant mesenchymal tumor, Adenocarcinoma, Brenner Tumor, Carcinoma, Renal Cell, Chondrosarcoma, Chordoma, Carcinoma, Adenoid Cystic, Fibroma, Hemangiopericytoma, Hemangiosarcoma, Leiomyosarcoma, Leukemia, Mast-Cell, Liposarcoma, Mastocytosis, Melanoma, Mesothelioma, Multiple Myeloma, Pleural Neoplasms, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial, Thymoma, Hypereosinophilic Syndrome, Sarcoma, Endometrial Stromal, Dermatofibrosarcoma, Rhabdomyosarcoma, Embryonal, Seminoma, Carcinoma, Ductal, Breast, Neurofibrosarcoma, Primary Myelofibrosis, Small Cell Lung Carcinoma

NCT01483014 2016-11-18

CONVERT

30 enrolled

Gastrointestinal Stromal Tumors

NCT00287846 2016-08-30

Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis

Phase 1/2 Completed

40 enrolled

Desmoid Tumors

NCT00387933 2015-10-14

Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma

37 enrolled

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00293124 2015-08-13

Open-label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors

Phase 3 Completed

125 enrolled

Gastrointestinal Stromal Tumors

NCT00030667 2015-04-15

Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood

CNSGastrointestinalSarcoma

100 enrolled

Neuroblastoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Gastrointestinal Stromal Tumors, Desmoplastic Small Round Cell Tumor

NCT01267695 2015-02-03

Perioperative Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor

20 enrolled

Gastrointestinal Stromal Tumors

NCT01281865 2014-10-08

Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma

Phase 1/2 Completed

14 enrolled 7 charts

Sarcoma, Sarcoma, Synovial

NCT01751919 2014-10-01

A Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400mg (1 Tablet) and Glivec Film-coated Tablet 100mg (4 Tablets)(Phase I)

GastrointestinalMyeloidOther hematologic neoplasmSarcoma

37 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Gastrointestinal Stromal Tumors

NCT00237185 2014-08-19

A Study of the Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Gene

148 enrolled 17 charts

GastrointestinalMyeloidOther hematologic neoplasmSarcoma

Piebaldism, Gastrointestinal Stromal Tumors

NCT02103322 2014-06-27

Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed Conditions

Phase 2/3 Completed

48 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Gastrointestinal Stromal Tumors

NCT00041197 2013-07-16

Imatinib Mesylate in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed By Surgery

Phase 3 Completed

732 enrolled

Gastrointestinal Stromal Tumors

NCT00031915 2013-06-19

Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma

Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Sarcoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00441155 2013-05-13

Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With Imatinib

14 enrolled

Neoplasms, Gastrointestinal Stromal Tumors

NCT00354068 2013-03-28

Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma

65 enrolled

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00615927 2013-03-15

Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)

64 enrolled 9 charts

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT00084630 2013-02-28

Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans

40 enrolled

Fibrosarcoma, Sarcoma, Dermatofibrosarcoma

NCT00025246 2013-02-20

Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery

89 enrolled

Gastrointestinal Stromal Tumors

NCT00613132 2013-02-20

Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG

78 enrolled

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT00613054 2012-12-05

Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma

27 enrolled

Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma

NCT01270984 2012-10-31

Imatinib

GastrointestinalMyeloidOther hematologic neoplasmSarcoma

30 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Gastrointestinal Stromal Tumors

NCT00085475 2012-09-24

Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma

17 enrolled